Literature DB >> 4816854

Instability of polymeric skin collagen in osteogenesis imperfecta.

M J Francis, R Smith, R J Bauze.   

Abstract

The structural polymeric collagen of the skin of 19 patients with osteogenesis imperfecta has been examined. In those with severe bone disease, who often have white sclerae, this collagen fraction is less resistant to depolymerization than that of age-matched controls, though the total amount is normal. In patients with less severe bone disease, whose sclerae are usually blue, the polymeric collagen may have normal stability but the total amount is reduced. These results suggest defective cross-linking of collagen in severe osteogenesis imperfecta.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4816854      PMCID: PMC1633248          DOI: 10.1136/bmj.1.5905.421

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  The extraction of polymeric collagen from biopsies of human skin.

Authors:  M J Francis; D C Macmillan
Journal:  Biochim Biophys Acta       Date:  1971-11-19

2.  Embryonic skin collagen. Replacement of the type of aldimine crosslinks during the early growth period.

Authors:  A J. Bailey; S P. Robins
Journal:  FEBS Lett       Date:  1972-04-01       Impact factor: 4.124

3.  Histochemical studies on cartilage and bone. III. Osteogenesis imperfecta.

Authors:  R H FOLLIS
Journal:  Bull Johns Hopkins Hosp       Date:  1953-12

Review 4.  Cross-linking of collagen.

Authors:  M L Tanzer
Journal:  Science       Date:  1973-05-11       Impact factor: 47.728

5.  Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1971-04-27       Impact factor: 3.162

6.  Osteogenesis imperfecta: a histometric analysis.

Authors:  K A Falvo; P G Bullough
Journal:  J Bone Joint Surg Am       Date:  1973-03       Impact factor: 5.284

7.  Polymeric collagen of skin in normal sunjects and in patients with inherited connective tissue disorders.

Authors:  M J Francis; R Smith; D C Macmillan
Journal:  Clin Sci       Date:  1973-05       Impact factor: 6.124

8.  Hydroxylysine in the N-terminal regions of the 1 - and 2 -chains of various collagens.

Authors:  M J Barnes; B J Constable; L F Morton; E Kodicek
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

9.  The determination of hydroxyproline in urine hydrolysates.

Authors:  I Bergman; R Loxley
Journal:  Clin Chim Acta       Date:  1970-02       Impact factor: 3.786

10.  Identification of three genetically distinct collagens by cyanogen bromide cleavage of insoluble human skin and cartilage collagen.

Authors:  E J Miller; E H Epstein; K A Piez
Journal:  Biochem Biophys Res Commun       Date:  1971-03-19       Impact factor: 3.575

View more
  4 in total

1.  [Syndrome of blue sclerae and keratoglobus (ocular type of Ehlers-Danlos syndrome (author's transl)].

Authors:  W Behrens-Baumann; H J Gebauer; U Langenbeck
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31

2.  Osteogenesis imperfecta: evidence for the existence of an abnormal amino acid sequence in the molecule of dermal collagen.

Authors:  J G Heathcote; S Al-Alawi
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

3.  Characterization of skin abnormalities in a mouse model of osteogenesis imperfecta using high resolution magnetic resonance imaging and Fourier transform infrared imaging spectroscopy.

Authors:  H C Canuto; K W Fishbein; A Huang; S B Doty; R A Herbert; J Peckham; N Pleshko; R G Spencer
Journal:  NMR Biomed       Date:  2011-08-15       Impact factor: 4.044

4.  Multiparametric Classification of Skin from Osteogenesis Imperfecta Patients and Controls by Quantitative Magnetic Resonance Microimaging.

Authors:  Beth G Ashinsky; Kenneth W Fishbein; Erin M Carter; Ping-Chang Lin; Nancy Pleshko; Cathleen L Raggio; Richard G Spencer
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.